Perspective Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
CATX
CUSIP
46489V302
Type
Equity
Class
COM NEW
Num filings
100
Total reported value, excl. options
$145 M
Manager Report Date Value ($000) Shares Option Type